Literature DB >> 12597447

A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model.

Andrew Suttie1, Abraham Nyska, Joseph K Haseman, Glenda J Moser, Theleria R Hackett, Thomas L Goldsworthy.   

Abstract

To improve the precision and consistency of experimental results, we have developed a scoring system for proliferative epithelial lesions in the mouse prostate based on histological growth patterns observed in individual lobes. Severity of proliferative lesions was divided into 6 categories; the grade of the most advanced lesion was identified for each lobe and its distribution estimated semiquantitatively. A numerical score combining grade and distribution of the most advanced lesion in each lobe was assigned and termed the "distribution-adjusted lesion grade"; the mean of these scores was calculated for each treatment group. Using this grading scheme, we assessed lesion development in ad libitum-fed and 20%-diet-restricted groups of TRAMP (Transgenic Adenocarcinoma of Mouse Prostate) mice that were started on study at 7 weeks of age and sacrificed when 11 and 20 weeks old. The anterior, dorsal, lateral, and ventral prostate lobes showed clear reductions in lesion severity in diet-restricted TRAMPS at 11 and 20 weeks. This method for scoring the epithelial pathology of the prostate in the TRAMP model with minimal to severe proliferative lesions utilizes the natural history of lesion development for assessing the effects of chemical and dietary interventions.

Entities:  

Mesh:

Year:  2003        PMID: 12597447     DOI: 10.1080/01926230390173842

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  22 in total

1.  Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.

Authors:  Pavlo L Kovalenko; Zhentao Zhang; Jun-Ge Yu; Yan Li; Steven K Clinton; James C Fleet
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

2.  Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.

Authors:  Mark E Stearns; Michael D Amatangelo; Devika Varma; Chris Sell; Shaun M Goodyear
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration.

Authors:  Jody T Mack; Kristi L Helke; Gabrielle Normand; CoDanielle Green; Danyelle M Townsend; Kenneth D Tew
Journal:  Cancer Lett       Date:  2010-10-30       Impact factor: 8.679

4.  Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.

Authors:  Seung Joon Kim; Ernest Amankwah; Shahnjayla Connors; Hyun Y Park; Maria Rincon; Heather Cornnell; Ganna Chornokur; Arig Ibrahim Hashim; Junsung Choi; Ya-Yu Tsai; Robert W Engelman; Nagi Kumar; Jong Y Park
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-05

5.  Suppression of prostate epithelial proliferation and intraprostatic progrowth signaling in transgenic mice by a new energy restriction-mimetic agent.

Authors:  Lisa D Berman-Booty; Po-Chen Chu; Jennifer M Thomas-Ahner; Brad Bolon; Dasheng Wang; Tiffany Yang; Steven K Clinton; Samuel K Kulp; Ching-Shih Chen
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-28

Review 6.  Modeling prostate cancer in mice: limitations and opportunities.

Authors:  Patrick J Hensley; Natasha Kyprianou
Journal:  J Androl       Date:  2011-06-16

7.  PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

Authors:  Leslie Ann Caromile; Kristina Dortche; M Mamunur Rahman; Christina L Grant; Christopher Stoddard; Fernando A Ferrer; Linda H Shapiro
Journal:  Sci Signal       Date:  2017-03-14       Impact factor: 8.192

8.  Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.

Authors:  Merrill J Christensen; Trevor E Quiner; Heather L Nakken; Edwin D Lephart; Dennis L Eggett; Paul M Urie
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

9.  PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis.

Authors:  Hong Pu; Craig Horbinski; Patrick J Hensley; Emily A Matuszak; Timothy Atkinson; Natasha Kyprianou
Journal:  Carcinogenesis       Date:  2014-08-30       Impact factor: 4.944

10.  Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice.

Authors:  Lisa D Berman-Booty; Jennifer M Thomas-Ahner; Brad Bolon; Michael J Oglesbee; Steven K Clinton; Samuel K Kulp; Ching-Shih Chen; Krista M D La Perle
Journal:  Toxicol Pathol       Date:  2014-04-17       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.